LFG
COGT icon

Larson Financial Group’s Cogent Biosciences COGT Stock Holding History

Larson Financial Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89K Hold
75
– – ﹤0.01% 2849
2025
Q4 		$2.66K Sell
75
-178
-70% -$5K ﹤0.01% 2702
2025
Q3 		$3.63K Buy
+253
New +$3K ﹤0.01% 2476
2025
Q2 		– Sell
-16
Closed -$96 – 3328
2025
Q1 		$96 Buy
+16
New +$125 ﹤0.01% 2917

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Larson Financial Group's COGT Position: Q1 2026 in Review

Larson Financial Group held its Cogent Biosciences (COGT) position steady in Q1 2026 at 75 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2849.

Larson Financial Group first reported a position in COGT in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.63K in Q3 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Larson Financial Group held 75 shares of Cogent Biosciences worth $2.89K as of Q1 2026.
  • Larson Financial Group left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2849 holding.
  • Larson Financial Group first reported a position in Cogent Biosciences in Q1 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Cogent Biosciences position peaked at $3.63K in Q3 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.